THE EFFECTS OF CYP3A INDUCTION AND INHIBITION ON ZURANOLONE PHARMACOKINETICS IN HEALTHY ADULTS

被引：0
|
作者：
Dunbar, J. [1 ]
Srinivas, N. [1 ]
Hoffmann, E. [1 ]
机构：
[1] Sage Therapeut, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-089
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [41] A novel in vivo approach to monitoring Cyp3a induction and inhibition by bioluminescent urinalysis
    Cali, James J.
    Ma, Dongping
    Bohm, Katarina
    Klaubert, Dieter H.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2025, 21 (03) : 335 - 342
  • [42] Influence of CYP3A and CYP2C19 Genetic Polymorphisms on the Pharmacokinetics of Cilostazol in Healthy Subjects
    Yoo, H-D
    Park, S-A
    Cho, H-Y
    Lee, Y-B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (03) : 281 - 284
  • [43] Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
    Chetan Lathia
    John Lettieri
    Frank Cihon
    Martha Gallentine
    Martin Radtke
    Pavur Sundaresan
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 685 - 692
  • [44] Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
    Lathia, C
    Lettieri, J
    Cihon, F
    Gallentine, M
    Radtke, M
    Sundaresan, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 685 - 692
  • [45] Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity
    Ines Fuchs
    Verena Hafner-Blumenstiel
    Christoph Markert
    Jürgen Burhenne
    Johanna Weiss
    Walter Emil Haefeli
    Gerd Mikus
    European Journal of Clinical Pharmacology, 2013, 69 : 507 - 513
  • [46] DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF STRONG CYP3A INHIBITION AND INDUCTION ON THE PHARMACOKINETICS OF AFICAMTEN, AND THE EFFECT OF AFICAMTEN ON P-GLYCOPROTEIN, IN HEALTHY PARTICIPANTS
    Xu, D.
    Lutz, J.
    Divanji, P.
    Cheplo, K.
    Li, J.
    Kupfer, S.
    German, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S85 - S85
  • [47] Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity
    Fuchs, Ines
    Hafner-Blumenstiel, Verena
    Markert, Christoph
    Burhenne, Juergen
    Weiss, Johanna
    Haefeli, Walter Emil
    Mikus, Gerd
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 507 - 513
  • [48] INHIBITORY EFFECTS OF SEVERAL CYP3A INHIBITORS ON CYP3A ACTIVITY IN CATS
    Shah, Syed S.
    Hayashi, Yuhei
    Motoyama, Seiko
    Sasaki, Kazuaki
    Shimoda, Minoru
    DRUG METABOLISM REVIEWS, 2008, 40 : 58 - 58
  • [49] Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects
    Shoaf, Susan E.
    Bricmont, Patricia
    Mallikaarjun, Suresh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (04) : 579 - 587
  • [50] Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats
    Lou, Yutao
    Song, Feifeng
    Cheng, Mengting
    Hu, Ying
    Chai, Yitao
    Hu, Qing
    Wang, Qiyue
    Zhou, Hongying
    Bao, Meihua
    Gu, Jinping
    Zhang, Yiwen
    PEERJ, 2023, 11
12345